Updates on histiocytic disorders. (Q38194538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Updates on histiocytic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Sarah R Vaiselbuh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Carl E Allen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

James A Whitlock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Oussama Abla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

9 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1329-1335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells

10 March 2020

cites work

1 reference

Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state

21 January 2018

1 reference

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells

21 January 2018

1 reference

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting

21 January 2018

1 reference

An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis

21 January 2018

1 reference

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

21 January 2018

1 reference

Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.

21 January 2018

1 reference

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.

21 January 2018

1 reference

B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

BRAF(E600) in benign and malignant human tumours

21 January 2018

1 reference

The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis.

21 January 2018

1 reference

Expansion of regulatory T cells in patients with Langerhans cell histiocytosis

21 January 2018

1 reference

Langerhans-cell histiocytosis 'insight into DC biology'.

21 January 2018

1 reference

IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy

21 January 2018

1 reference

Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions

21 January 2018

1 reference

Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

21 January 2018

1 reference

Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

21 January 2018

1 reference

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

21 January 2018

1 reference

Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry

21 January 2018

1 reference

BRAF targeted therapy changes the treatment paradigm in melanoma

21 January 2018

1 reference

Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma

21 January 2018

1 reference

Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

Skin tumorigenesis stimulated by Raf inhibitors relies upon Raf functions that are dependent and independent of ERK.

21 January 2018

1 reference

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

21 January 2018

1 reference

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction

21 January 2018

1 reference

Drug therapy for the treatment of Langerhans cell histiocytosis.

21 January 2018

1 reference

Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.

21 January 2018

1 reference

Familial haemophagocytic reticulosis

21 January 2018

1 reference

The expanding spectrum of hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.

21 January 2018

1 reference

Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome

21 January 2018

1 reference

Functional significance of the perforin/granzyme cell death pathway

21 January 2018

1 reference

Inherited defects in lymphocyte cytotoxic activity

21 January 2018

1 reference

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

Elevated Granzyme B in Cytotoxic Lymphocytes is a Signature of Immune Activation in Hemophagocytic Lymphohistiocytosis

21 January 2018

1 reference

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

21 January 2018

1 reference

How I treat hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens

21 January 2018

1 reference

Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis.

21 January 2018

1 reference

Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab.

21 January 2018

1 reference

Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice

21 January 2018

1 reference

Uncommon histiocytic disorders: the non-Langerhans cell histiocytoses

21 January 2018

1 reference

Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages

21 January 2018

1 reference

Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature

21 January 2018

1 reference

Rosai-Dorfman disease complicated by autoimmune haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates.

21 January 2018

1 reference

Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease

21 January 2018

1 reference

Intracranial Rosai-Dorfman disease treated with microsurgical resection and stereotactic radiosurgery. Case report

21 January 2018

1 reference

Extranodal Rosai-Dorfman disease of the kidney

21 January 2018

1 reference

[Extra-nodal Rosai-Dorfman disease: a case report with thyroid involvement].

21 January 2018

1 reference

Rosai-Dorfman disease presenting as a solitary mediastinal mass.

21 January 2018

1 reference

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

21 January 2018

1 reference

Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment

21 January 2018

1 reference

"Catastrophic systemic lupus erythematosus" with Rosai-Dorfman sinus histiocytosis. Successful treatment with anti-CD20/rutuximab

21 January 2018

1 reference

Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system

21 January 2018

1 reference

Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients

21 January 2018

1 reference

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.25017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24610771%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference